Literature DB >> 8097828

Enhanced systemic nitric oxide production in inflammatory bowel disease.

D D Tran, J J Visser, M O Pool, M A Cuesta, K Hoekman, A S Peña, S G Meuwissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8097828     DOI： 10.1016/0140-6736(93)93166-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Induction of iNOS in a rat model of acute colitis.

Authors:  E Kankuri; M Z Asmawi; R Korpela; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

2.  Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  F Obermeier; G Kojouharoff; W Hans; J Schölmerich; V Gross; W Falk
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.

Authors:  M Ferretti; P Gionchetti; F Rizzello; A Venturi; P Stella; F Corti; J Mizrahi; M Miglioli; M Campieri
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

4.  Plasma nitrate concentration in infective gastroenteritis and inflammatory bowel disease.

Authors:  R S Dykhuizen; J Masson; G McKnight; A N Mowat; C C Smith; L M Smith; N Benjamin
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

5.  Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis.

Authors:  Yesuf Taha; Yngve Raab; Anders Larsson; Marie Carlson; Lars Lööf; Bengt Gerdin; Magnus Thörn
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.